Knowledge Center
Article / Jun 01, 2009
Substandard APIs: we must tackle the problem together
Source:
Pharmaceutical Technology Europe, June, 2009
Contrary to what some would have you believe, the use of substandard APIs in European medicines puts patient health and pharmaceutical manufacturers' reputations at risk. Most APIs destined for the EU come from Asian plants that have never been inspected by an EU official. To ensure a minimum level of quality, agencies and regulators from both sides of the Atlantic must work together to provide API compliance oversight.
Related links
Also in the Knowledge Center
/ Apr 20, 2017
Method of production of inhalable composite particles using a three-fluid nozzle
Read more
Scientific Article
/ Dec 07, 2016
Impact of Spray Drying on Superoxide Dismutase Activity in Composite Systems with Optimal Aerodynamic Performance for Dry Powder Inhalers
Read more
Scientific Article
/ Dec 07, 2016
Optimization of Supercritical CO2 Assisted Spray Drying for the Production of Inhalable Composite Particles
Read more
Scientific Article